Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance of Atypical Antipsychotics in Early Onset Bipolar Disorder
NCT00048802Phase 4Completed
- Sponsor
- Northwell Health
- Start
- Aug 2002
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine, risperidone, quetiapine, ziprasidone, aripiprazole in bipolar disorder (BD), sponsored by Northwell Health. Started Aug 2002; status: completed.
02
Drugs
olanzapinerisperidonequetiapineziprasidonearipiprazole
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00048802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048802.